Skip to main content

Table 4 Summary of HCMV-tetramer in HLA-A24 young children

From: Large scale analysis of pediatric antiviral CD8+ T cell populations reveals sustained, functional and mature responses

Age(yr.) (n = 202)

< 1 (n = 66)

1 (n = 46)

2 (n = 38)

3 (n = 25)

4 (n = 27)

Number of tet(+)

11(17%)

11(24%)

7(18%)

4(16%)

6(22%)

CD8

17.0 ± 5.0

20.0 ± 6.9

19.2 ± 4.2

22.3 ± 3.8

24.8 ± 5.6

Tet(%)

0.07 ± 0.08

0.05 ± 0.05

0.06 ± 0.10

0.01 ± 0

0.03 ± 0.03

Tet/CD8(%)

0.34 ± 0.32*

0.16 ± 0.15*

0.28 ± 0.55*

0.05 ± 0.01*

0.11 ± 0.12

  1. HCMV-tetramer positive: Tet/CD8(+) Lymphocytes ≥ 0.04%
  2. *: P values < 0.05